{
  "id": 3351329,
  "title": "2 Stocks That Could Capitalize on the GLP-1 Boom",
  "url": "https://urgent.news/2026/08/25/2-stocks-that-could-capitalize-on-the-glp-1-boom-3351329",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-25T19:18:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/08/25/2-stocks-that-could-capitalize-on-the-glp-1-boom/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "GLP-1 drugs have experienced a surge in demand in recent years, thanks to advancements in the field and an expanding list of treatable conditions. Investors are eager to capitalize on this ongoing boom, and they have ample opportunities to do so, beyond merely investing in the current leaders in the sector: Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). Two additional stocks to consider are CVS Health (NYSE:CVS) and Roche (OTC:RHHBY).\n\nCVS Health, a prominent pharmacy chain, has demonstrated strong performance over the past 18 months. The company has successfully tackled several challenges that have impacted its profitability, such as soaring medical costs. In the second quarter, CVS Health reported a 7.3% year-over-year increase in revenue to $106.1 billion, alongside a notable 42.5% rise in adjusted earnings per share (EPS) from $1.92 to $2.58.",
  "summary": "They aren't the most prominent names in the GLP-1 space, but they are worth a second look.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "2 Stocks That Could Capitalize on the GLP-1 Boom",
        "url": "https://urgent.news/2026/08/25/2-stocks-that-could-capitalize-on-the-glp-1-boom",
        "published": "2026-08-25T19:38:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}